Alkermes plc is a pharmaceutical manufacturing and biopharmaceutical company developing innovative medicines to help patients with serious chronic conditions.

Biotechnology

Alkermes

Alkermes' headquarters in Dublin 4, Ireland

Richard F. Pops

Craig Hopkinson

Jim Schoener

Michael Rossotti

Shane Cooke

Blair C. Jackson

Sandy Coombs

Thomas Harvey

David J. Gaffin

Cato T. Laurencin

Christopher I. Wright

Emily Peterson Alva

Andy Wilson

Richard B. Gaynor

Frank Anders Wilson

Shane M. Cooke

Nancy L. Snyderman

Brian P. Mckeon

Nancy S. Lurker

The Directors Team at Alkermes consists of senior leaders overseeing various functional areas across the company. This team plays a critical role in shaping strategic initiatives, spearheading business development, ensuring operational excellence, and guiding the company towards its mission of developing innovative medicines for patients with serious chronic conditions.

Directors Team

The Leadership Team at Alkermes is responsible for setting the strategic direction of the company, ensuring compliance with regulatory standards, and overseeing the development of innovative medicines for serious chronic conditions. This team coordinates cross-functional efforts in areas such as clinical development, finance, legal affairs, human resources, and marketing to drive operational excellence and enhance patient outcomes. By leveraging diverse expertise, the Leadership Team fosters collaboration and guides Alkermes in achieving its mission of improving patients' lives.

Leadership Team

The Senior Vice Presidents at Alkermes are responsible for leading and managing critical areas across the company, including policy and government relations, program and project management, corporate and legal affairs, medical development, operations, finance, investor relations, information technology, clinical development, sales and marketing, and business development. They play a key role in shaping strategic initiatives, ensuring compliance, advancing medical innovation, and driving overall company performance towards achieving its mission of developing innovative medicines for patients with serious chronic conditions.

Senior Vice Presidents

The Finance Team at Alkermes is responsible for managing the company's financial health by overseeing budgeting, forecasting, and financial planning and analysis. They ensure accurate financial reporting, guide investment decisions, and develop strategies to optimize financial performance in support of the company's mission to develop innovative medicines. The team works collaboratively across departments to align financial goals with corporate objectives and to support long-term growth and stability.

Finance team

The Marketing and Sales team at Alkermes is responsible for developing and executing strategic initiatives to promote the company's innovative medicines, such as Lybalvi. This includes consumer marketing, market access strategy, digital marketing, field incentive compensation, strategic pricing, and contract analytics. Additionally, the team manages sales analytics, commercial data, and ensures the overall effectiveness of commercial efforts to maximize market penetration and improve patient access to treatments.

Marketing and Sales

The Human Resources and Talent Management team at Alkermes oversees employee recruitment, development, and retention strategies. They manage HR operations, implement leadership development programs, ensure compliance with travel and expense policies, and leverage technology to streamline HR processes, all aimed at building a highly skilled and motivated workforce to support the company's mission of developing innovative medicines.

��

Alkermes

Org chart

Board & advisors

Teams

Directors Team

Leadership Team

Senior Vice Presidents

Finance team

Marketing and Sales

Human Resources and Talent Management

Offices

��������

Alkermes

Org chart

Board & advisors

Teams

Directors Team

Leadership Team

Senior Vice Presidents

Finance team

Marketing and Sales

Human Resources and Talent Management

Offices

Related companies

��